News | December 10, 2013

American Shared Hospital Services Announces Final 2014 CMS Gamma Knife and Proton Therapy Reimbursement Rates

December 10, 2013 — American Shared Hospital Services, a provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced that the Centers for Medicare and Medicaid Services (CMS) has posted its final Medicare hospital outpatient prospective payment rates for calendar year 2014.
 
Effective Jan. 1, 2014, CMS Gamma Knife delivery code reimbursement will be increased to $3,592 from the previous rate of $3,301, a 9 percent increase. It is estimated that including ancillary services and outlier adjustments, if applicable, Gamma Knife centers can receive Medicare reimbursement of up to around $9,000 per treatment under the recently announced CMS rates.
 
CMS’s 2014 proton therapy delivery code rates per daily session are $872 ($1,137 in 2013) for a simple treatment and $1,205 ($682 in 2013) for an intermediate or complex treatment.
 
For more information: www.ashs.com

Related Content

Liver cancer tumor scanning using an MRI
News | Proton Therapy | November 04, 2019
November 4, 2019 – Two new studies support and inform the use of proton radiation therapy to treat patients with hepa
Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform
News | Brachytherapy Systems, Women's Healthcare | October 23, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation...
MD Anderson and Varian Partner to Optimize Radiation Oncology Treatment
News | Treatment Planning | October 18, 2019
The University of Texas MD Anderson Cancer Center and Varian announced a new strategic collaboration to develop an...
Videos | Radiation Oncology | October 11, 2019
Lorraine Drapek, DNP, nurse practitioner, radiation oncology, GI service,...
Patient Treatments With ViewRay's MRIdian Linac Begin in New England
News | Image Guided Radiation Therapy (IGRT) | October 08, 2019
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac...
ProTom International received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Radiance 330 proton therapy system
News | Proton Therapy | October 07, 2019
ProTom International received 510(k) clearance from the U.S.